MedTrace Logo

Incidence of MIS-C and Other Complications Following SARS-CoV-2 Infection

NCT05186597 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2023-02-23

No results posted yet for this study

Summary

Multisystem inflammatory syndrome in children (MIS-C) is a rare severe complication to SARS-CoV-2 infection in children. It has been reported to occur in approximately one of 3,000 to 4,000 unvaccinated children during the COVID-19 waves dominated by variant Alpha of SARS-CoV-2. However, the incidences following SARS-CoV-2 infection with variant delta and omicron, as well as among vaccinated children and adolescents with SARS-CoV-2 is yet unexplored.

The investigators aim to estimate the incidence of MIS-C and in vaccinated and unvaccinated children and adolescents following variants delta and omicron, and other complications of SARS-CoV-2 including complication due to SARS-CoV-2 lock-down, based on a nationwide prospective population-based cohort study.

Conditions

  • SARS CoV 2 Infection
  • Multisystem Inflammatory Disease, Pediatric, COVID-19 Related
  • Multisystem Inflammatory Syndrome in Children
  • COVID-19 Pandemic

Sponsors & Collaborators

  • Innovation Fund Denmark

    collaborator INDIV

  • Ministry of Education, Denmark

    collaborator OTHER_GOV

  • Rigshospitalet, Denmark

    lead OTHER

Eligibility

Min Age
0 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-15
Primary Completion
2024-07-14
Completion
2024-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05186597 on ClinicalTrials.gov